Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 8 » Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives
Please verify you are not a robot.